Around the World

There is a growing sense that the United States is finally close to something on cannabis. Not certainty. Not clarity. But momentum. Rescheduling cannabis from Schedule I to Schedule III, if it happens, would be meaningful. It would signal that the federal government is prepared to acknowledge medical utility, reduce some of the most punitive […]

The recently announced acquisition of CanAdelaar by Canadian cannabis company Cronos Group for €57.5 million marks a significant milestone for the European cannabis industry. Yet while the transaction highlights renewed international interest in the Dutch market, it also exposes an uncomfortable truth: even market leaders can find themselves trapped in valuation bottlenecks. The numbers tell

When people talk about Cannafest, they usually highlight the scale of the event. The full exhibition halls. The thousands of visitors. The international brands. But the heart of the story sits somewhere else. It sits with a tall, calm founder who never set out to become an event powerhouse. It sits with Lukáš Běhal. Lukáš

Colombia’s cannabis industry just got a political and regulatory tailwind. President Gustavo Petro is calling on the United States to abandon prohibition and embrace a regulated global trade in cannabis, while his own government is opening domestic flower sales and expanding export channels. For Germany and the wider EU, that could mean a new, reliable

Zurich continues to serve as Europe’s laboratory for regulated cannabis distribution. The city council has requested an extension of the “Züri-Can” project until 2028 – and after three years, the results are remarkable. What began as an experiment is increasingly developing into a functioning market model with clear public health benefits and growing social acceptance.

The debate around cannabis legalisation in the United Kingdom has been gaining momentum in recent years – fuelled by calls from the London Drugs Commission to decriminalise small amounts. Yet Prime Minister Keir Starmer has now drawn a clear line: under his Labour government, there will be no legalisation of recreational cannabis. Starmer draws a

Europe is increasingly moving into the spotlight of international cannabis investors. Just a few weeks after the acquisition of Remexian Pharma by High Tide in Germany, another deal is making headlines: Casa Verde Capital, the venture fund co-founded by Snoop Dogg, has invested £4.5 million into the UK medical cannabis clinic Mamedica. Founded in 2022,

What You Need to Know About the World’s Next Cannabis Superpower Executive Summary: With Anutin Charnvirakul – Thailand’s “Cannabis King” – now serving as Prime Minister, the Southeast Asian nation is positioned to become one of the world’s largest cannabis markets. Our complete analysis reveals why Thailand could challenge established markets like Canada and Germany

Thailand’s healthcare technology landscape is rapidly evolving as new cannabis regulations reshape opportunities for startups and investors. The Department of Thai Traditional and Alternative Medicine (DTAM), in partnership with the SME Council and leading health tech firms, is pioneering a digital transformation with a centralized platform for medical cannabis control. Key Regulatory Changes DTAM has rolled out